MesaGreen Shows Progress and Promise Moving Forward
With the final report now complete MGP in association with the University of Minnesota, the Mayo Clinic and Oval Medical Technologies are currently preparing two Abstracts of the research results to be presented at the December 2021 Annual Meeting of the American Epilepsy Society. Also, the team has begun writing a research manuscript for publication in a high-impact journal of veterinary medicine.
MGP’s product will fill a significant gap and an unmet need in canine health care. We met the challenges presented by the Covid-19 pandemic and completed our studies in 2020. The data generated in these studies provide the basis for pre-IANDA discussions with U.S. FDA’s Center for Veterinary Medicine. MGP anticipates engaging CVM in the early fall of 2021.